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Garcı´a, Bibian, and Maria-Jesu´s Obrego´n. Growth
factor regulation of uncoupling protein-1 mRNA expression
in brown adipocytes. Am J Physiol Cell Physiol 282:
C105–C112, 2002. First published October 3, 2001; 10.1152/
ajpcell.01396.2000.—To study the effect of the mitogens epi-
dermal growth factor (EGF), acidic and basic fibroblast
growth factors (aFGF and bFGF), and vasopressin on brown
adipocyte differentiation, we analyzed the expression of un-
coupling protein-1 (UCP-1) mRNA. Quiescent brown preadi-
pocytes express high levels of UCP-1 mRNA in response to
triiodothyronine (T3) and norepinephrine (NE). The addition
of serum or the mitogenic condition aFGF 1 vasopressin 1
NE or EGF 1 vasopressin 1 NE decreases UCP-1 mRNA. A
second addition of mitogens further decreases UCP-1 mRNA.
Treatment with aFGF or bFGF alone increases UCP-1
mRNA, whereas the addition of EGF or vasopressin dramat-
ically reduces UCP-1 mRNA levels. The continuous presence
of T3 increases UCP-1 mRNA levels in cells treated with
EGF, aFGF, or bFGF. The effect of T3 on the stimulation of
DNA synthesis also was tested. T3 inhibits the mitogenic
activity of aFGF and bFGF. In conclusion, mitogens like
aFGF or bFGF allow brown adipocyte differentiation,
whereas EGF and vasopressin inhibit the differentiation
process. T3 behaves as an important hormone that regulates
both brown adipocyte proliferation and differentiation.
proliferation; differentiation; thermogenesis
THE MAIN FUNCTION of brown adipose tissue (BAT) is to
produce extra heat by nonshivering thermogenesis,
especially in demanding situations such as cold expo-
sure. This function is accomplished by the mitochon-
drial protein, thermogenin, also called uncoupling pro-
tein-1 (UCP-1), a BAT-specific protein present only in
the inner mitochondrial membrane of brown adipo-
cytes (27). UCP-1 provides heat by uncoupling the
oxidative phosphorylation, dissipating as heat the en-
ergy that otherwise would be stored as ATP (21).
BAT development occurs in mammals during the
perinatal period, and in the rat, it reaches its maximal
activity and thermogenic capacity during the first week
of postnatal life, due to the norepinephrine (NE) re-
leased from the sympathetic fibers in response to the
cold experienced by the newborn after delivery (20, 22).
With increasing age and body size, BAT degenerates,
loosing its thermogenic capacity, but can be reactivated
in situations such as cold exposure or overeating. The
reactivation implies increases in cell proliferation of
brown adipocyte precursor cells present in the tissue
and the differentiation of those cells to thermogenic
brown adipocytes (8, 11, 19, 25). Several studies in vivo
have shown that the NE released from the sympathetic
nerve endings is the main mediator of the proliferative
stimulus in BAT activation (8, 11, 25) and also stimu-
lates the proliferation of brown fat cells in primary
cultures in the presence of serum (7). In a previous
study, our group showed that NE has a low mitogenic
effect per se but increases the stimulation of DNA
synthesis exerted by serum, epidermal growth factor
(EGF), basic fibroblast growth factor (bFGF), or vaso-
pressin in quiescent brown preadipocytes (10). NE also
regulates the differentiation process, mainly by induc-
ing UCP-1 expression at the transcriptional level (5,
27). The thyroid hormone triiodothyronine (T3) has
been reported to be required for the optimal UCP-1
gene expression in response to the noradrenergic stim-
ulus in vivo (2, 31) and in dispersed and cultured
brown adipocytes (1, 13). T3 per se is able to induce the
transcription of UCP-1 gene and stabilizes its mRNA
in fetal rat brown adipocytes in primary culture (12).
The same group has reported that IGF-I stimulated
UCP-1 expression in brown adipocytes from rat fetuses
(17). Besides these effects of NE, T3, and IGF-I, little is
known about other hormones or growth factors in-
volved in the acquisition of the differentiated state. In
our previous study (10), we showed that brown adipo-
cytes cultured in the presence of different mitogenic
conditions, including serum, express UCP-1 mRNA
when stimulated adrenergically in the presence of T3,
but the expression level was variable, depending on the
mitogenic combinations used. In the present work we
analyze 1) the effect of the growth factors EGF, acidic
fibroblast growth factor (aFGF), and bFGF and the
hormone vasopressin on the expression level of UCP-1
gene in brown adipocytes and 2) the role of T3 in
modulating the effects of these mitogens in UCP-1
expression as well as on DNA synthesis stimulation.
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MATERIALS AND METHODS
Materials. Dulbecco’s modified Eagle’s medium (DMEM)
was obtained from GIBCO (Uxbridge, UK). Newborn calf
serum (NCS) was from Flow (Paisley, UK). Antibiotics were
from a local pharmacy. Bovine serum albumin (BSA; in
solution at 22%, pH 7.2) was from Ortho Diagnostic Systems,
Johnson & Johnson (Raritan, NJ). Collagenase, bovine insu-
lin, ascorbic acid, guanidinium-HCl, 3-(N-morpholino)pro-
panesulfonic acid (MOPS), dithiothreitol (DTT), NE, and
vasopressin were from Sigma (St. Louis, MO). aFGF, bFGF,
and EGF were from Boehringer Mannheim (Mannheim, Ger-
many). aFGF was used in the presence of 50 mg/ml heparin
(final concentration), as recommended for proper biological
activity. PD-98059 (PD), bisindolylmaleimide I (Bis), and
LY-294002 (LY) were from Calbiochem (Darmstadt, Ger-
many). [a-32P]dCTP (3,000 Ci/mmol) and [3H]thymidine were
from Amersham International (Amersham, UK). Formamide
was from Fluka or Merck, and the oligolabeling system was
from Pharmacia (Uppsala, Sweden). Nytran membranes for
RNA blotting were purchased from Schleicher & Schuell
(Dassel, Germany), and the glass fiber filter mats for thymi-
dine incorporation were from Wallac Oy (Turku, Finland). All
other chemicals were reagent grade or molecular biology
grade.
Cell isolation and culture. Brown fat precursor cells were
isolated from the interscapular brown adipose tissue of 20-
day-old rats as described by Ne´chad et al. (18), with the
difference that we did not perform the hypoosmotic shock.
The process involved collagenase digestion, separation of
mature adipocytes by flotation, and subsequent filtration
through 25-mm silk filters, obtaining precursor cells by cen-
trifugation. The precursor cells obtained from each animal
were divided into two culture flasks (Nunclon, 25 cm2; Nunc,
Roskilde, Denmark), each containing 5 ml of culture medium
consisting of DMEM supplemented with 3.5 nM insulin, 10
mM HEPES, 50 IU/ml penicillin, 50 mg/ml streptomycin, 25
mM sodium ascorbate (culture medium), and 10% NCS. The
cells were incubated at 37°C in an atmosphere of 5% CO2 in
air with 95% humidity. Cells were washed on day 1 (2,000
cells/cm2), and culture medium was changed every other day.
For proliferation assays, preconfluent cells (day 2–3) were
harvested using 0.2% collagenase in DMEM, washed, and
seeded in 24-multiwell tissue culture plates (Falcon; Becton
Dickinson Labware, Lincoln Park, NJ) at a density of 8,000
cells/cm2 with 1 ml of culture medium supplemented with
10% NCS. After 6 h, the cells were washed twice with me-
dium and maintained for 48 h in culture medium supple-
mented with 0.2% BSA (time 0). This was the starting point
for mitogenic stimulation.
For RNA analysis, preconfluent cells (day 3) were used.
After being washed and maintained for 48 h in culture
medium supplemented with 0.2% NCS, quiescent cells were
stimulated by the addition of the different growth factors and
hormones. After 2 days in culture, 5 nM T3 was added and,
16 h later, RNA isolation was performed, after a 4-h pretreat-
ment with 10 mM NE.
Proliferation assays. Growth factors, hormones, or serum
was added to the cells at time 0 (10), at the concentrations
indicated in each experiment. For [3H]thymidine incorpora-
tion assays, quiescent cells were stimulated with the appro-
priate mitogens and hormones at time 0 in the presence of
[3H]thymidine (1 mCi/ml). After 40 h of exposure, the medium
was discarded, and the cells were removed from the plate
with the use of a trypsin-EDTA solution. Thereafter, the
contents of each well were harvested onto glass fiber filters
with a cell harvester from Inotech (Dottikon, Switzerland),
and the radioactivity incorporated into DNA was determined
with a beta-scintillation counter (MicroBeta) from Wallac Oy.
RNA analysis. At the end of the experiments, the cells
were dissolved in 1 ml of hot guanidine-HCl extraction
buffer, and RNA was isolated after ethanol precipitation as
described previously (14). RNA concentration was deter-
mined by measuring the optical density (OD) at 260 nm, and
the ratio of OD at 260 nm to that at 280 nm (260/280) was
always around 2.0. Samples of total RNA (20 mg) were elec-
trophoresed in 1% agarose gels containing 2.2 M formalde-
hyde. Methylene blue staining revealed the presence of equal
amounts of RNA in each lane. RNA was blotted into nylon
filters (Nytran, NY13). Hybridization and washing were car-
ried out as previously described (10) by using a rat UCP-1
cDNA (6) and cyclophilin cDNA probes labeled by random
oligopriming. The quantitation of the signal was performed
by using an Instant Imager (Packard).
Statistics. Mean values given were obtained from at least
three different culture flasks or wells. All experiments pre-
sented were repeated at least three times, and representative
Northern blots are shown. The SE values given in figure
legends are the mean SEs calculated by ANOVA. Data were
submitted to one-way ANOVA after having been tested for
homogeneity of variance by using Bartlett’s procedure for
groups of unequal size. Square root or logarithmic transfor-
mations were used to ensure homogeneity of variance when
not achieved with the raw data. Significant differences
among groups were assessed by using the protected least
significant difference (LSD) test. All statistical calculations
were performed by following the method described by Snede-
cor and Cochran (32).
RESULTS
Stimulation of proliferation by serum and growth
factors. In a previous study, we described several
growth factors that stimulate DNA synthesis in quies-
cent brown preadipocytes, such as EGF, aFGF, and
bFGF (10). The addition of vasopressin plus NE in-
duced a substantial increment in DNA synthesis stim-
ulation elicited by each growth factor, reaching levels
comparable to those found in response to 10% serum.
When quiescent cultures are stimulated with these
mitogenic combinations for 72 h, a substantial stimu-
lation of cell proliferation is observed. Figure 1 shows
microphotographs of cultures untreated or treated
with serum or EGF (5 ng/ml), aFGF (1 ng/ml), or bFGF
(5 ng/ml) plus vasopressin (20 nM) and NE (1 mM) for
72 h. There is evidence that the mitogenic combina-
tions and serum stimulate cellular proliferation and
that cultures reach confluence, as compared with qui-
escent unstimulated cells.
UCP-1 mRNA level in quiescent and serum-treated
cultures. We recently reported that quiescent brown
adipocytes cultured in the presence of serum or the
different mitogenic combinations mentioned above
were able to express the differentiation marker UCP-1
only when stimulated adrenergically in the presence of
T3 (10). In the present study, first of all, we wanted to
measure UCP-1 mRNA level in quiescent cultures to
study the state of differentiation of quiescent brown
adipocytes. For this purpose, cultures of brown preadi-
pocytes were maintained during 48 h in low-serum
conditions, as described in MATERIALS AND METHODS. Af-
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terward, RNA isolation was performed in half of the
flasks containing quiescent cells, whereas the remain-
ing flasks were treated with 10% serum, and RNA was
analyzed 72 h later. All flasks received 5 nM T3 and 1
mM NE 16 and 4 h, respectively, before RNA isolation.
Figure 2 shows that quiescent cells express UCP-1
mRNA when stimulated adrenergically in the presence
of T3; however, when those cells are stimulated with
serum, UCP-1 gene expression substantially de-
creased. Cy mRNA is shown as control.
Effect of mitogenic stimulation on UCP-1 mRNA
level. Given that serum treatment stimulates prolifer-
ation and inhibits the ability of cells to express the
differentiation marker UCP-1, we tested the effect of
successive additions of the mitogenic combinations de-
scribed above on UCP-1 mRNA expression. For this
purpose, quiescent cells were cultured in the absence
or presence of aFGF (1 ng/ml) plus vasopressin (20 nM)
plus NE (1 mM) or EGF (5 ng/ml) plus vasopressin plus
NE or 10% NCS for 72 h. Half of the flasks received a
second addition of mitogens 24 h after the first addi-
tion. All flasks received 5 nM T3 and 10 mM NE 16 and
4 h, respectively, before RNA isolation. Results are
shown in Fig. 3. The UCP-1 mRNA level in quiescent
cells was much higher than that in stimulated cells
(P , 0.05). The second addition of mitogens resulted, in
all cases, in a further reduction of UCP-1 mRNA level,
and the transcript was almost undetectable in cultures
that received two additions of the mitogenic combina-
tion of EGF plus vasopressin plus NE.
UCP-1 mRNA level in cells cultured in the presence of
EGF, aFGF, and bFGF: effect of chronic T3 treatment.
Although the mitogenic stimulation results in an im-
portant reduction of UCP-1 gene expression compared
with the level found in quiescent cells, the different
mitogenic combinations produced quite different ef-
fects. Thus we studied the effect of different growth
factors, added alone, on the expression of UCP-1
mRNA. In the same assay, the effect of the continuous
presence of T3 was analyzed. Quiescent cultures were
left untreated or were treated with aFGF (1 ng/ml),
EGF (5 ng/ml), or bFGF (5 ng/ml) in the absence or
presence of 5 nM T3, and UCP-1 mRNA was analyzed
after 72 h of exposure. Before RNA isolation, T3 (5 nM)
and NE (1 mM) were added, as described above. Figure
4 shows that cells treated with aFGF but without
vasopressin and NE expressed the differentiation
marker UCP-1, and the mRNA level observed is higher
Fig. 1. Brown adipocyte proliferation in response to different mitogenic conditions. Quiescent preadipocytes
(maintained for 48 h in low-serum conditions) were cultured for 72 h in absence (A) or presence (B) of newborn calf
serum (NCS; 10%) or the following mitogenic combinations: vasopressin (20 nM) plus norepinephrine (NE; 1 mM)
plus epidermal growth factor (EGF; 5 ng/ml) (C), acidic fibroblast growth factor (aFGF; 1 ng/ml) (D), or basic
fibroblast growth factor (bFGF; 5 ng/ml) (E).
Fig. 2. Uncoupling protein (UCP)-1 gene expression in quiescent
preadipocytes. Brown preadipocytes were maintained 48 h in low-
serum conditions to induce a quiescent state. At that time, RNA
isolation was performed in half of the flasks while the other half were
treated with 10% NCS for a further 72 h, and RNA isolation was then
performed. All flasks received triiodothyronine (T3; 5 nM) and NE
(10 mM) 16 and 4 h, respectively, before RNA isolation. A represen-
tative Northern blot is shown. Cy, cyclophilin; shown as control.
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than that detected in quiescent unstimulated cells.
Treatment with bFGF exhibited the same effect as
aFGF. However, the presence of EGF resulted in a
substantial reduction in the UCP-1 mRNA level com-
pared with that in quiescent unstimulated cells (Fig. 4).
The continuous presence of T3 resulted in an in-
crease of UCP-1 mRNA expression in quiescent cells as
well as in cells treated with the growth factors EGF,
aFGF, or bFGF.
Vasopressin and NE effect on UCP-1 expression. As
with the growth factors aFGF, bFGF, and EGF, we
wanted to study the role of vasopressin and NE in the
regulation of UCP-1 gene expression. Figure 5 shows
that the incubation of quiescent cultures during 72 h
with 20 nM vasopressin prevents the induction of
UCP-1 gene expression by T3 and NE (P , 0.05)
compared with the level reached by quiescent cells.
Furthermore, the presence of vasopressin reduced
UCP-1 mRNA levels in cells treated with the growth
factors EGF (5 ng/ml), aFGF (1 ng/ml), and bFGF (5
ng/ml) and in cells treated with NE (1 mM). The addi-
tion of NE produced a further decrease in UCP-1 ex-
pression in cells treated with the different growth
factors plus vasopressin.
Effect of the protein kinase C inhibitor Bis. In an
attempt to understand the differential effect of EGF
and FGFs on the noradrenergic stimulation of UCP-1
mRNA expression, we tested the effect of several in-
hibitors of different signaling pathways. First, Bis, a
known inhibitor of protein kinase C (PKC; isoforms a,
b, g, d, and e) was used. Figure 6 shows that Bis
increases the expression of UCP-1 in cells treated with
EGF and aFGF and completely reverts the inhibition
exerted by EGF on UCP-1 mRNA to the level observed
in quiescent cells. These results suggest the presence of
a PKC with inhibitory effect on the stimulated UCP-1
mRNA expression.
In other experiments we also used PD, an inhibitor of
mitogen-activated protein kinase kinase (MAPKK) ac-
tivity (MEK), as well as LY, a specific inhibitor of
phosphatidylinositol (PI) 3-kinase. Both PD and LY
inhibited UCP-1 mRNA expression in the presence of
EGF, aFGF, or bFGF (results not shown), suggesting
that both MAPKK (MEK) and PI 3-kinase signaling
pathways are cooperative signals for UCP-1 mRNA
expression using NE plus T3.
T3 effect on DNA synthesis stimulation. Although T3
is necessary for BAT development and thermogenesis
Fig. 4. Effect of EGF, aFGF, bFGF, and T3 on UCP-1 gene expres-
sion. Quiescent brown preadipocytes were treated with aFGF (1
ng/ml) or EGF (5 ng/ml) (A, left) or with bFGF (5 ng/ml) (A, right) in
the absence (2) or presence (1) of T3 (5 nM) for 72 h, and RNA
isolation was then performed. All flasks received T3 (5 nM) and NE
(10 mM) 16 and 4 h, respectively, before RNA isolation. A: 2 repre-
sentative Northern blots. B: relative UCP-1 mRNA levels, expressed
in arbitrary units, obtained by quantitation of UCP-1 mRNA signal
of 3 independent experiments and normalized by using Cy values.
The mean SE 5 21.5. *P , 0.05 vs. corresponding cells in the absence
of T3. #P , 0.05 vs. quiescent cells (C) in the absence of T3.
Fig. 3. Effect of different mitogenic conditions on UCP-1 mRNA
level. Quiescent brown preadipocytes were untreated (C) or treated
with NCS (10%) or the mitogenic combinations vasopressin (20 nM)
plus NE (1 mM) plus either aFGF (1 ng/ml) or EGF (5 ng/ml) for 72 h.
Twenty-four hours after the first addition, half of the flasks received
a second addition of serum or mitogens. All flasks received T3 (5 nM)
and NE (10 mM) 16 and 4 h, respectively, before RNA isolation.
A: representative Northern blot. B: relative UCP-1 mRNA levels,
expressed in arbitrary units, obtained by quantitation of UCP-1
mRNA signal of 3 independent experiments and normalized by using
Cy values. The mean SE 5 1. *P , 0.05, double vs. single addition of
mitogens.
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(3, 23), its role on brown adipocyte proliferation has not
been studied yet. In this report we analyze the effect of
T3 addition on DNA synthesis stimulation elicited by
the growth factors EGF, aFGF, and bFGF and by
vasopressin. The results shown in Fig. 7 reveal that the
presence of T3 did not alter the [3H]thymidine incor-
poration level reached in response to vasopressin and
decreased slightly the mitogenic activity of EGF. How-
ever, T3 considerably reduced the stimulation elicited
by aFGF and inhibited the effect of bFGF on DNA
synthesis stimulation. T3 when added alone had no
effect on [3H]thymidine incorporation compared with
untreated quiescent cells (data not shown).
DISCUSSION
During BAT recruitment in response to cold expo-
sure, there must be a variety of growth factors and
hormones regulating the proliferation of brown prea-
dipocytes, as well as the differentiation of those cells
into mature thermogenic adipocytes. In our previous
study, we identified several growth factors and hor-
mones (EGF, platelet-derived growth factor, aFGF,
bFGF, and vasopressin) that stimulated DNA synthe-
sis in brown preadipocytes, and we showed that NE
was able to potentiate the effect of some of those
growth factors. We established mitogenic conditions
that stimulated DNA synthesis to a level comparable
with that reached in response to 10% NCS. Those cells
growing in these mitogenic conditions (growth factor 1
Fig. 5. Effect of vasopressin and NE on expression of the UCP-1
gene. Quiescent brown preadipocytes were treated with NCS (10%),
EGF (5 ng/ml), aFGF (1 ng/ml), or bFGF (5 ng/ml) in the absence or
presence of vasopressin (20 nM) or vasopressin plus NE (1 mM) for
72 h. Other flasks were treated with vasopressin or NE, or with both
hormones. All flasks received T3 (5 nM) and NE (10 mM) 16 and 4 h,
respectively, before RNA isolation. Vas, vasopressin. A: representa-
tive Northern blot. B: relative UCP-1 mRNA levels, expressed in
arbitrary units, obtained by quantitation of UCP-1 mRNA signal of 3
independent experiments and normalized by using Cy values. The
mean SE 5 0.84. *P , 0.05 vs. each treatment (EGF, aFGF, bFGF,
or NE) in the absence of vasopressin. #P , 0.05 vs. quiescent cells
(C).
Fig. 6. Effect of bisindolylmaleimide I (Bis) on UCP-1 gene expres-
sion. Quiescent brown preadipocytes were untreated (C) or treated
with NCS (10%), EGF (5 ng/ml), aFGF (1 ng/ml), or bFGF (5 ng/ml)
for 72 h. Half of the flasks received Bis (1 mM) 1 h before growth
factors were added. All flasks received T3 (5 nM) and NE (10 mM) 16
and 4 h, respectively, before RNA isolation. A: representative North-
ern blot. B: relative UCP-1 mRNA levels, expressed in arbitrary
units, obtained by quantitation of UCP-1 mRNA signal of 3 indepen-
dent experiments and normalized by using Cy values. The mean
SE 5 16. *P , 0.05 vs. corresponding cells in the absence of Bis.
Fig. 7. Effect of T3 on the mitogenic activity of growth factors.
Quiescent brown preadipocytes were exposed for 40 h to EGF (5
ng/ml), aFGF (1 ng/ml), bFGF (5 ng/ml), or vasopressin (20 nM) in
the absence or presence of T3 (5 nM) and in the continuous presence
of 1 mCi/ml [3H]thymidine. T3 added alone had no effect on [3H]thy-
midine incorporation. Results are expressed as fold increases rela-
tive to values in untreated quiescent cells. The mean SE 5 14.5. *P ,
0.05 vs. corresponding cells in the absence of T3.
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vasopressin 1 NE) were able to express UCP-1 gene
when stimulated by T3 and NE. In this work we were
interested in studying the effect of each mitogen on
UCP-1 mRNA levels and the role of T3 in regulating
UCP-1 mRNA content in response to these mitogens.
For this purpose, we first analyzed the differentiation
state of quiescent brown preadipocytes before their
stimulation with the mitogens. We have shown that
nonconfluent cultures of quiescent brown preadipo-
cytes (maintained 48 h in low-serum conditions) are
able to express UCP-1 gene when stimulated by T3 and
NE. The addition of 10% serum to these cultures pro-
duces a substantial reduction in the UCP-1 mRNA
level. The observed reduction in UCP-1 mRNA level in
response to serum could be due to 1) the mitogenic
stimulation that makes cells enter the cell cycle and
acquire a proliferative state and 2) certain growth
factors and hormones present in serum that could
interfere with the stimulatory action of T3 and/or NE
on the UCP-1 gene expression.
We report evidence that both situations might take
place. First, we have shown that the treatment of
quiescent brown preadipocytes under the mitogenic
conditions we described in a previous study (10),
growth factor plus vasopressin 1 NE, stimulates cel-
lular proliferation and results in a reduction of UCP-1
mRNA level compared with quiescent unstimulated
cells. The UCP-1 mRNA level declines even more when
cultures are treated with a second addition of mitogens
or serum. These results confirm that the quiescent
state favors cellular differentiation even in cultures
that have not yet reached confluence and that the
mitogenic stimulation reduces the ability of brown adi-
pocytes to express the differentiation marker UCP-1.
Second, quiescent brown preadipocytes cultured in
the presence of aFGF or bFGF keep the ability to
express UCP-1 mRNA, but cells treated with EGF or
vasopressin fail to express UCP-1 mRNA in response to
T3 and NE. Thus growth factors like aFGF and bFGF,
besides being potent mitogens for brown adipocytes,
allow differentiation. One of those growth factors,
bFGF, has been shown to be involved in BAT enlarge-
ment during cold acclimation (34), and its expression is
greatly enhanced in response to NE (35). These find-
ings, in addition to our results, confirm that bFGF is an
important growth factor for brown fat cell proliferation
and differentiation.
Conversely, EGF or vasopressin regulates the ex-
pression of the UCP-1 gene negatively, interfering with
the stimulatory action of NE and/or T3 on UCP-1
mRNA expression. Many studies in vitro, as well as in
vivo, have established EGF as an inhibitor of white
adipocyte differentiation. EGF inhibits white preadipo-
cyte differentiation in primary cultures (29, 33) and,
when administered to neonatal rats, increases the
number of white adipocyte precursors, reducing the
ability of these cells to undergo differentiation (30),
and elicits a significant reduction in midscapular skin
temperature as an indicator of brown adipose tissue
thermogenesis (9). EGF is also a potent mitogen that
prevents the adipogenic differentiation of 3T3-L1 cells
(4). The same behavior has been observed in thyroid
cells, where EGF stimulates cellular proliferation and
prevents the acquisition of the differentiated state (28).
In this study we report, for the first time, evidence of
EGF action on the differentiation of brown precursor
cells. Our results confirm EGF as an important growth
factor for adipose cells and suggest that EGF, in addi-
tion to vasopressin, could play an important role inter-
fering in the process of brown adipocyte differentiation.
In this respect, high levels of c-Jun, present in nondif-
ferentiated brown adipocytes as compared with differ-
entiated cells, have been reported to repress the basal
and cAMP-mediated expression of UCP-1 gene (36).
These authors postulate that c-Jun levels could deter-
mine the cellular state, e.g., proliferative or differenti-
ated in brown adipocytes. c-Jun is a transcription fac-
tor that stimulates progression of the cell cycle (26) and
mediates the proliferative response to growth factors in
multiple cell types (15). It remains to be elucidated
whether c-Jun is involved in the dedifferentiative effect
of EGF and vasopressin.
To understand the molecular mechanisms underly-
ing the differential effects of these growth factors, we
analyzed the signaling pathways involved in the effect
of these growth factors on UCP-1 mRNA expression. It
is well accepted that after the binding of the growth
factors to their tyrosine kinase receptors, several sig-
naling pathways are initiated, leading to the activation
of a cascade of events that involve the activation of
MAPK, PI 3-kinase, and PKC (16). The results ob-
tained with the PI 3-kinase and MEK inhibitors did not
allow us to discriminate between the effect of the dif-
ferent growth factors, since both inhibited UCP-1
mRNA expression regardless of which mitogen was
tested. Our results with the PKC inhibitor Bis suggest
the involvement of an unknown PKC isoform in the
inhibition of UCP-1 mRNA expression. Bis potentiated
the effect of aFGF and completely reverted the inhibi-
tory effect of EGF on UCP-1 expression, suggesting
that this PKC isoform could be involved in the dedif-
ferentiative effect of EGF. Further work needs to be
done to identify the specific PKC involved in the mod-
ulation of UCP-1 expression.
In the present paper we also have analyzed the role
of T3 in the regulation of UCP-1 expression and of DNA
synthesis stimulation in response to these mitogens.
We have shown that the continuous presence of T3
increases UCP-1 mRNA content in quiescent cells as
well as in cells treated with the growth factors EGF,
aFGF, or bFGF. We also have reported that T3 reduces
the mitogenic effect of aFGF and inhibits the stimula-
tion of DNA synthesis elicited by bFGF, indicating that
T3 interferes with the mitogenic signaling pathways
activated in response to these growth factors. Although
an interaction of thyroid hormone receptors and the
transcription factor AP1, which is induced in response
to many growth factors, has been reported (37), the
precise mechanism underlying the role of T3 in brown
adipocyte proliferation remains to be studied.
Our findings are in agreement with the inhibitory
effects of T3 on proliferation in N2a cell lines (neuro-
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blastoma), where T3 leads to decreases in the levels of
the cyclin D1, a key step in the progression of the cell
cycle, and to increases in cyclin kinase inhibitor
p27kip1, which are associated with increases in the
cyclin-dependent kinase 2 (Cdk2) (24).
In conclusion, our results describe for the first time a
permissive role of aFGF and bFGF and a negative role
for EGF and vasopressin on the differentiation of
brown adipocytes, measured as UCP-1 mRNA level. T3
behaves as an important hormone that may control
both brown adipocyte proliferation and differentiation.
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